Answers from the studies
AOD-9604 questions have direct study answers.
Twenty-two answers keep animal results apart from human results. No answer gives a dose plan.
AOD9604 changed fat use only in animal studies
What did the animal work show? The compound slowed new fat in animal cells. After 14 days, obese mice weighed less and held less fat. The lasting change needed the beta-3 fat-cell control [4].
The beta-3 control helps fat cells burn fuel. That result came from mice. People did not get clear weight loss [10]. Mouse results can't promise the same result for you.
AOD9604 does not send the full hormone message
The compound copies only growth hormone's tail. It doesn't send the full hormone's growth message. It also leaves IGF-1, the blood growth signal, unchanged [1]. The copied tail and full hormone act differently.
In lab tests, the tail slowed a key fat-making step [2]. The beta-3 fat-cell control became more active in obese mice [4]. Those findings explain the drug idea. They didn't prove weight loss in people.
AOD9604 is a peptide, not a steroid
Is AOD-9604 a steroid? No. It is a peptide, or short protein chain [3]. A steroid has a different chemical build.
AOD-9604 copies part of human growth hormone. Steroids and peptides act in different ways. The compound doesn't send the full hormone's growth message [1]. Peptide is the right word.
AOD-9604 is a copied growth hormone tail
What does AOD-9604 mean? It means "Anti-Obesity Drug 9604." The compound is a peptide, or short protein chain. It copies the tail of growth hormone.
The lab copy has one extra protein part [3]. That change doesn't prove it works better. The main human study found no weight-loss benefit.
The compound began as a weight-loss pill. It is not an approved drug [9]. A study compound is not approved care.
AOD-9604 did not bring clear human weight loss
Did the compound cause weight loss in people? The studies say no. Roughly six trials included about 900 obese adults. Side effects looked much like those with placebo [5].
The main larger study found no added weight loss. The company then ended the work [9]. Mice had shown real fat changes. People did not get that benefit.
AOD-9604 slowed new fat in animal tests
How did the compound affect fat in tests? It slowed a key step that makes new fat [2]. Obese mice also burned more stored fat [4]. The beta-3 fat-cell control became more active.
These findings came from cells and animals. The compound didn't send the full hormone's growth message. It also left IGF-1, the blood growth signal, unchanged [1]. Early tests found more slowing of new fat than freeing stored fat [3].
AOD-9604 is not FDA approved
Is AOD-9604 approved for any illness? No. Metabolic Pharmaceuticals ended its weight-loss work after the main trial failed [9]. That work produced no approved human dose.
AOD-9604 appears in the FDA record of withdrawn compounding nominations. Its nomination was withdrawn; FDA's safety warnings remain, and that withdrawal does not permit compounding. For a U.S. patient seeking peptide care by prescription, the clinician must be licensed and may refuse; both the patient's state and the chosen treatment restrict the choices. A compounded AOD-9604 medicine has no FDA approval.
AOD-9604 safety studies were short
How much human safety testing was done? Roughly six trials included about 900 obese people. Side effects looked much like those with placebo [5]. Problems linked to full growth hormone were not seen.
The compound still isn't approved. Human study time stopped at about 24 weeks [9]. Products outside normal pharmacies may not match their labels. The trials can't prove that use without care is safe.
AOD9604 does not raise the IGF-1 blood growth signal
Does AOD-9604 raise IGF-1, the blood growth signal? The studies say no. The compound doesn't send the full hormone's growth message [1]. That was a main aim of the drug design.
Long feeding tests in rats and monkeys found no damaged chromosomes. They also found no signs that the compound poisoned the animals [7]. Those checks are useful animal facts. They don't settle long-term safety in people.
AOD-9604 drug work ended after human failure
Why did the drug work end? The main larger trial found no added weight loss over placebo. Metabolic Pharmaceuticals stopped the work around 2007 [9]. The compound never won approval.
Mice had lost weight and body fat. People did not get the same help. A later review says many weight-loss drug ideas fail this way [11]. Good mouse results weren't enough.
AOD9604 left pig blood within minutes
How long did the compound remain in pig blood? Half remained after about 3 minutes. The study placed it into a vein [7]. The pig's body then broke the chain into smaller parts.
That fast drop came from pigs, not people. It doesn't tell you what a person would feel. Human weight-loss studies mostly used tablets. The pig result gives no safe human amount.
AOD9604 tablets reached the blood
Did the tablets reach the blood? Yes. Metabolic Pharmaceuticals used tablets in human weight-loss work [5]. Rats and monkeys also swallowed the compound [7].
Other studies put it into a vein or animal belly. A rabbit study used knee-joint shots. No human study checked shots under the skin. No method is approved for personal care.
The beta-3 fat control mattered only in mice
What kept the mouse weight change going? The beta-3 control inside fat cells was needed. Mice born without the beta-3 control lost the lasting weight effect. The finding belongs only to obese mice.
Mice without the beta-3 control still burned more calories briefly [4]. They also burned more stored fat. The quick change did not need that cell control. None of this proves weight loss in people.
AOD9604 was designed to limit sugar trouble
Did AOD-9604 itself raise the same blood-sugar concern? The rat test used related hormone tails instead. Blood sugar rose briefly, while insulin stayed high longer [13]. The finished compound wasn't tested in that exact form.
Long animal tests found no clear sign of poisoning [7]. They did not prove safety for long human use. A blood test can check your sugar. Your doctor can weigh your risk.
AOD9604 side effects resembled placebo
What did human trials find about side effects? Roughly six trials included about 900 people. Side effects looked much like those with placebo [5]. Personal reports mention a red or sore shot spot.
Human studies did not pass about 24 weeks [9]. Rare or late harm may have been missed. Personal reports can't rule out that harm. Part of the safety question stays open.
AOD9604 is banned in competitive sports
Is AOD-9604 banned in sport? Yes, at all times. The world group that sets sport drug rules bars hormone parts [6]. The ban covers this compound even though it isn't full growth hormone.
Special drug tests can find the compound. A usual growth-hormone test may work another way. For an athlete, the ban is the key fact. The source page names the testing paper.
The main AOD9604 trial found no added weight loss
What happened in the main human trial? The compound brought no added weight loss over placebo. Across other work, side effects looked much like placebo [5]. A fair safety result did not make the drug work.
Metabolic Pharmaceuticals ended the work around 2007 [9]. The compound was never approved for any illness. Few side effects and good results aren't the same. Only the side-effect finding looked hopeful here.
The AOD9604 peptide has no sound weight-loss figure
Is there a sound human weight-loss figure? No. The main larger study found no added loss over placebo. The company then ended the work [9]. Any promised number would go past the evidence.
Some people report change while eating less and moving more. Either habit can lower weight by itself. The compound can't be credited with certainty. The studies give you no sound amount of weight loss.
AOD9604 helped rabbit cartilage, not human knees
Did AOD-9604 help arthritic knees? Only a rabbit study found help. The study used 32 rabbits with knee arthritis. Each knee got 0.25 milligrams of AOD-9604 each week.
Some knees also got 6 milligrams of hyaluronic acid, a joint fluid gel. After 4-7 weeks, cartilage looked less worn than with salt water [14]. No human knee study has been published. The finding does not prove help for your knee.
AOD9604 has not been shown to save muscle
Does the compound keep muscle during weight loss? No human study proved that claim. The main weight-loss trial failed [9]. There was no proved fat loss to compare with muscle.
Personal reports often say muscle stayed unchanged. Strength and healing also stayed much the same. The compound doesn't act like full growth hormone [1]. Claims of saving muscle go beyond the studies.
AOD9604 slowed new fat in animal cells
What changed in the fat studies? AOD-9604 slowed a key step that makes new fat [2]. Obese mice then burned more stored fat [4]. The beta-3 fat-cell control became more active.
Those findings came from animals and cells. The compound didn't send the full hormone's growth message. It also left IGF-1, the blood growth signal, unchanged [1]. Early tests found more slowing of new fat than freeing stored fat [3].
AOD-9604 study methods do not guide personal shots
Do the study methods show how to have a shot? No. Human weight-loss studies used tablets [5]. Other studies placed the compound into a vein [7].
A rabbit study used a knee-joint shot [14]. Mouse studies used shots into the belly [4]. No published human study checked shots under the skin. A personal report isn't proof from a trial.